Atika Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Atika Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-54,000	Closed	-$9.31M	–	93
2019 Q2	$9.31M	Sell	54,000 -2,500	-4%	-$432K	1.83%	15
2019 Q1	$9.52M	Buy	+56,500	New	+$8.41M	1.94%	13
2018 Q4	–	Sell	-29,000	Closed	-$5.01M	–	105
2018 Q3	$5.01M	Buy	+29,000	New	+$4.18M	0.9%	41
2018 Q1	–	Sell	-31,000	Closed	-$4.09M	–	92
2017 Q4	$4.09M	Sell	31,000 -1,500	-5%	-$176K	1.58%	29
2017 Q3	$3.3M	Buy	32,500 +10,500	+48%	+$1.12M	0.95%	37
2017 Q2	$2.21M	Sell	22,000 -8,000	-27%	-$861K	0.77%	48
2017 Q1	$3.63M	Sell	30,000 -17,998	-37%	-$2.21M	1.78%	21
2016 Q4	$5.36M	Sell	47,998 -1,002	-2%	-$121K	3.19%	7
2016 Q3	$6.5M	Buy	49,000 +32,000	+188%	+$3.06M	2.66%	8
2016 Q2	$1.56M	Buy	+17,000	New	+$1.43M	0.67%	45

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atika Capital Management's GWPH Position: Q3 2019 in Review

Atika Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 54,000 shares — an estimated $9.31M sold.

Atika Capital Management first reported a position in GWPH in Q2 2016 and held it in 10 quarters. The position peaked at $9.52M in Q1 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Atika Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Atika Capital Management sold 54,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $9.31M.
Atika Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 10 quarters.
Atika Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9.52M in Q1 2019.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Atika Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.